ArticleEmerging infectious diseases2011
Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009.
Article in Emerging infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Impact of Coronavirus Disease (COVID)-19 on the Indigenous Population of Brazil: A Systematic Review.Journal of racial and ethnic health disparities · 2026Pooled it
- The association between socioeconomic status and pandemic influenza: Systematic review and meta-analysis.PloS one · 2021Pooled it
- The role of chronic disease in the disparity of influenza incidence and severity between indigenous and non-indigenous Australian peoples during the 2009 influenza pandemic.BMC public health · 2022Article
- Broad-Based Influenza-Specific CD8Viruses · 2021Article
- Roadmap to recovery: Reporting on a research taskforce supporting Indigenous responses to COVID-19 in Australia.The Australian journal of social issues · 2021Article
- Epidemiological trends in notified influenza cases in Australia's Northern Territory, 2007-2016.Influenza and other respiratory viruses · 2020Article
- The public health response to COVID-19: balancing precaution and unintended consequences.Annals of epidemiology · 2020Article
- Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.Frontiers in immunology · 2019Review
- Article
- Health Challenges of the Pacific Region: Insights From History, Geography, Social Determinants, Genetics, and the Microbiome.Frontiers in immunology · 2019Review
- Article
- Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities.Proceedings of the National Academy of Sciences of the United States of America · 2014Article
- Admission to hospital for pneumonia and influenza attributable to 2009 pandemic A/H1N1 influenza in First Nations communities in three provinces of Canada.BMC public health · 2013Article
- Closing the Gaps: competing estimates of Indigenous Australian life expectancy in the scientific literature.Australian and New Zealand journal of public health · 2013Article
- Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Influenza and other respiratory viruses · 2013Article
- Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore.Emerging infectious diseases · 2013Article
- Indigenous populations health protection: a Canadian perspective.BMC public health · 2012Article
- Influenza Burden and Transmission in the Tropics.Current epidemiology reportsReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pandemic (H1N1) 2009 influenza spread through the Northern Territory, Australia, during June-August 2009. We performed 2 cross-sectional serologic surveys on specimens from Northern Territory residents, with 445 specimens obtained prepandemic and 1,689 specimens postpandemic. Antibody titers were determined by hemagglutination inhibition against reference virus A/California/7/2009 on serum samples collected opportunistically from outpatients. All specimens had data for patients' gender, age, and address, with patients' indigenous status determined for 94.1%. Protective immunity (titer >40) was present in 7.6% (95% confidence interval [CI] 5.2%-10.1%) of prepandemic specimens and 19.5% (95% CI 17.6%-21.4%) of postpandemic specimens, giving a population-standardized attack rate of 14.9% (95% CI 11.0%-18.9%). Prepandemic proportion of immune persons was greater with increasing age but did not differ by other demographic characteristics. Postpandemic proportion of immune persons was greater in younger groups and around double in indigenous persons. Postpandemic proportion immune was geographically heterogeneous, particularly among remote-living and indigenous groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.